Genetic and epigenetic trends in telomere research: A novel way in immunoepigenetics

Cellular and Molecular Life Sciences

Volumn 72, Issue 21, 2015, Pages 4095-4109

  Melicher, Dora ^a   Buzas, Edit I ^a   Falus, Andras ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Epigenetic regulation; Immune cells; In vitro; Telomerase; Telomere length; Telomere twin studies; Twin epigenetics

Indexed keywords

TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TERT PROTEIN, HUMAN;

AGING; ALTERNATIVE RNA SPLICING; CHROMATIN STRUCTURE; EPIGENETICS; GENETIC VARIABILITY; GRANULOCYTE; HISTONE METHYLATION; HUMAN; IMMUNOCOMPETENCE; IMMUNOGENETICS; LYMPHOCYTE; MAST CELL; MONOCYTE; MORTALITY; NONHUMAN; PROTEIN PROCESSING; REVIEW; SENESCENCE; TELOMERE; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING; TRANSCRIPTION REGULATION; BONE MARROW CELL; CYTOLOGY; GENETIC EPIGENESIS; GENETICS; METABOLISM; MUTATION; PHYSIOLOGY; PROCEDURES; TRENDS; TWINS;

AGING; EPIGENESIS, GENETIC; HUMANS; IMMUNOGENETICS; LYMPHOCYTES; MUTATION; MYELOID CELLS; TELOMERASE; TELOMERE; TWIN STUDIES AS TOPIC; TWINS;

EID: 84944149719     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-015-1991-2     Document Type: Review

References (184)

1. Blackburn EH (2001) Switching and signaling at the telomere. Cell 106(6):661-673
2. van Steensel B, Smogorzewska A, de Lange T (1998) TRF2 protects human telomeres from end-to-end fusions. Cell 92(3):401-413
3. de Lange T (2005) Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 19(18):2100-2110
4. Blasco MA (2007) The epigenetic regulation of mammalian telomeres. Nat Rev Genet 8(4):299-309
5. Griffith JD et al (1999) Mammalian telomeres end in a large duplex loop. Cell 97(4):503-514
6. Palm W, de Lange T (2008) How shelterin protects mammalian telomeres. Annu Rev Genet 42:301-334
7. Cesare AJ, Reddel RR (2010) Alternative lengthening of telomeres: models, mechanisms and implications. Nat Rev Genet 11(5):319-330
8. Hockemeyer D et al (2006) Recent expansion of the telomeric complex in rodents: two distinct POT1 proteins protect mouse telomeres. Cell 126(1):63-77
9. Chan SW, Blackburn EH (2002) New ways not to make ends meet: telomerase. DNA damage proteins and heterochromatin. Oncogene 21(4):553-563
10. Collins K, Mitchell JR (2002) Telomerase in the human organism. Oncogene 21(4):564-579
11. Cohen SB et al (2007) Protein composition of catalytically active human telomerase from immortal cells. Science 315(5820):1850-1853
12. Venteicher AS et al (2009) A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis. Science 323(5914):644-648
13. Kim NW et al (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266(5193):2011-2015
14. Wright WE et al (1996) Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 18(2):173-179
15. Morrison SJ et al (1996) Telomerase activity in hematopoietic cells is associated with self-renewal potential. Immunity 5(3):207-216
16. Blackburn EH, Greider CW, Szostak JW (2006) Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat Med 12(10):1133-1138
17. Hathcock KS, Jeffrey Y, Hodes RJ (2005) In vivo regulation of telomerase activity and telomere length. Immunol Rev 205:104-113
18. Blasco MA (2005) Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet 6(8):611-622
19. Lansdorp PM (2009) Telomeres and disease. EMBO J 28(17):2532-2540
20. Mitchell JR, Wood E, Collins K (1999) A telomerase component is defective in the human disease dyskeratosis congenita. Nature 402(6761):551-555
21. Calado RT, Young NS (2009) Telomere diseases. N Engl J Med 361(24):2353-2365
22. Aubert G, Lansdorp PM (2008) Telomeres and aging. Physiol Rev 88(2):557-579
23. Walne AJ et al (2007) Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10. Hum Mol Genet 16(13):1619-1629
24. Savage SA et al (2008) TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. Am J Hum Genet 82(2):501-509
25. Vulliamy T et al (2008) Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita. Proc Natl Acad Sci USA 105(23):8073-8078
26. Yamaguchi H et al (2003) Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome. Blood 102(3):916-918
27. Marrone A et al (2004) Heterozygous telomerase RNA mutations found in dyskeratosis congenita and aplastic anemia reduce telomerase activity via haploinsufficiency. Blood 104(13):3936-3942
28. Ly H et al (2005) Functional characterization of telomerase RNA variants found in patients with hematologic disorders. Blood 105(6):2332-2339
29. Vulliamy TJ et al (2005) Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure. Blood Cells Mol Dis 34(3):257-263
30. Armanios MY et al (2007) Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med 356(13):1317-1326
31. Qazilbash MH et al (1997) A new syndrome of familial aplastic anemia and chronic liver disease. Acta Haematol 97(3):164-167
32. Carulli L, Anzivino C (2014) Telomere and telomerase in chronic liver disease and hepatocarcinoma. World J Gastroenterol 20(20):6287-6292
33. Calado RT et al (2009) A spectrum of severe familial liver disorders associate with telomerase mutations. PLoS ONE 4(11):e7926
34. Satoh M et al (2009) Effect of intensive lipid-lowering therapy on telomere erosion in endothelial progenitor cells obtained from patients with coronary artery disease. Clin Sci 116(11-12):827-835
35. Fitzpatrick AL et al (2007) Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am J Epidemiol 165(1):14-21
36. Farzaneh-Far R et al (2008) Prognostic value of leukocyte telomere length in patients with stable coronary artery disease - data from the heart and soul study. Arterioscler Thromb Vasc Biol 28(7):1379-1384
37. Wang YY et al (2011) Association of shorter mean telomere length with large artery stiffness in patients with coronary heart disease. Aging Male 14(1):27-32
38. Epel ES et al (2009) The rate of leukocyte telomere shortening predicts mortality from cardiovascular disease in elderly men. Aging (Albany NY) 1(1):81-88
39. Salpea KD, Humphries SE (2010) Telomere length in atherosclerosis and diabetes. Atherosclerosis 209(1):35-38
40. Salpea KD et al (2010) Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation. Atherosclerosis 209(1):42-50
41. Al-Attas OS et al (2010) Adiposity and insulin resistance correlate with telomere length in middle-aged Arabs: the influence of circulating adiponectin. Eur J Endocrinol 163(4):601-607
42. Cao Y, Bryan TM, Reddel RR (2008) Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells. Cancer Sci 99(6):1092-1099
43. Shay JW, Wright WE (2011) Role of telomeres and telomerase in cancer. Semin Cancer Biol 21(6):349-353
44. Londono-Vallejo JA (2008) Telomere instability and cancer. Biochimie 90(1):73-82
45. Bryan TM et al (1997) Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 3(11):1271-1274
46. Bryan TM et al (1995) Telomere elongation in immortal human-cells without detectable telomerase activity. EMBO J 14(17):4240-4248
47. Dunham MA et al (2000) Telomere maintenance by recombination in human cells. Nat Genet 26(4):447-450
48. O'Sullivan RJ, Almouzni G (2014) Assembly of telomeric chromatin to create alternative endings. Trends Cell Biol 24(11):675-685
49. Murnane JP et al (1994) Telomere dynamics in an immortal human cell-line. EMBO J 13(20):4953-4962
50. Natarajan S, McEachern MJ (2002) Recombinational telomere elongation promoted by DNA circles. Mol Cell Biol 22(13):4512-4521
51. Arora R et al (2014) RNaseH1 regulates TERRA-telomeric DNA hybrids and telomere maintenance in ALT tumour cells. Nat Commun 5:5220
52. Balk B et al (2013) Telomeric RNA-DNA hybrids affect telomere-length dynamics and senescence. Nat Struct Mol Biol 20(10):1199-1205
53. Cusanelli E, Chartrand P (2015) Telomeric repeat-containing RNA TERRA: a noncoding RNA connecting telomere biology to genome integrity. Front Genet 6:143
54. Gibbons RJ et al (2000) Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern of DNA methylation. Nat Genet 24(4):368-371
55. Lewis PW et al (2010) Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres. Proc Natl Acad Sci USA 107(32):14075-14080
56. Drane P et al (2010) The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3. Genes Dev 24(12):1253-1265
57. Schoeftner S, Blasco MA (2009) A 'higher order' of telomere regulation: telomere heterochromatin and telomeric RNAs. EMBO J 28(16):2323-2336
58. Benetti R, Garcia-Cao M, Blasco MA (2007) Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres. Nat Genet 39(2):243-250
59. Hu J et al (2012) Antitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancer. Cell 148(4):651-663
60. van Dongen J et al (2012) The continuing value of twin studies in the omics era. Nat Rev Genet 13(9):640-653
61. Bell JT, Saffery R (2012) The value of twins in epigenetic epidemiology. Int J Epidemiol 41(1):140-150
62. Heath AC, Jardine R, Martin NG (1989) Interactive effects of genotype and social environment on alcohol consumption in female twins. J Stud Alcohol 50(1):38-48
63. Bell JT, Spector TD (2011) A twin approach to unraveling epigenetics. Trends Genet 27(3):116-125
64. Tan Q et al (2013) Twins for epigenetic studies of human aging and development. Ageing Res Rev 12(1):182-187
65. Kaszubowska L (2008) Telomere shortening and ageing of the immune system. J Physiol Pharmacol 59(Suppl 9):169-186
66. Slagboom PE, Droog S, Boomsma DI (1994) Genetic determination of telomere size in humans: a twin study of three age groups. Am J Hum Genet 55(5):876-882
67. Lange K, Weeks D, Boehnke M (1988) Programs for pedigree analysis - Mendel, Fisher, and Dgene. Genet Epidemiol 5(6):471-472
68. Kosciolek BA, Rowley PT (1998) Human lymphocyte telomerase is genetically regulated. Genes Chromosom Cancer 21(2):124-130
69. Jeanclos E et al (2000) Telomere length inversely correlates with pulse pressure and is highly familial. Hypertension 36(2):195-200
70. Bischoff C et al (2005) The heritability of telomere length among the elderly and oldest-old. Twin Res Hum Genet 8(5):433-439
71. Bischoff C et al (2005) Telomere length among the elderly and oldest-old. Twin Res Hum Genet 8(5):425-432
72. Vogler GP (1993) Methodology for genetic-studies of twins and families - Neale, Mc, Cardon, Lr. Behav Genet 23(1):107-108
73. Broer L et al (2013) Meta-analysis of telomere length in 19,713 subjects reveals high heritability, stronger maternal inheritance and a paternal age effect. Eur J Hum Genet 21(10):1163-1168
74. Cawthon RM et al (2003) Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 361(9355):393-395
75. Honig LS et al (2006) Shorter telomeres are associated with mortality in those with APOE epsilon4 and dementia. Ann Neurol 60(2):181-187
76. Bakaysa SL et al (2007) Telomere length predicts survival independent of genetic influences. Aging Cell 6(6):769-774
77. Kimura M et al (2008) Telomere length and mortality: a study of leukocytes in elderly Danish twins. Am J Epidemiol 167(7):799-806
78. Deelen J et al (2014) Leukocyte telomere length associates with prospective mortality independent of immune-related parameters and known genetic markers. Int J Epidemiol 43(3):878-886
79. Martin-Ruiz CM et al (2005) Telomere length in white blood cells is not associated with morbidity or mortality in the oldest old: a population-based study. Aging Cell 4(6):287-290
80. Bischoff C et al (2006) No association between telomere length and survival among the elderly and oldest old. Epidemiology 17(2):190-194
81. Harris SE et al (2006) The association between telomere length, physical health, cognitive ageing, and mortality in non-demented older people. Neurosci Lett 406(3):260-264
82. Huda N et al (2007) Shared environmental factors associated with telomere length maintenance in elderly male twins. Aging Cell 6(5):709-713
83. Rufer N et al (1999) Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. J Exp Med 190(2):157-167
84. Nawrot TS et al (2004) Telomere length and possible link to X chromosome. Lancet 363(9408):507-510
85. Andrew T et al (2006) Mapping genetic loci that determine leukocyte telomere length in a large sample of unselected female sibling pairs. Am J Hum Genet 78(3):480-486
86. Cherkas LF et al (2008) The association between physical activity in leisure time and leukocyte telomere length. Arch Intern Med 168(2):154-158
87. Hjelmborg JB et al (2015) The heritability of leucocyte telomere length dynamics. J Med Genet 52(5):297-302
88. Okuda K et al (2002) Telomere length in the newborn. Pediatr Res 52(3):377-381
89. Akkad A et al (2006) Telomere length in small-for-gestational-age babies. BJOG 113(3):318-323
90. Benetos A et al (2014) Sex difference in leukocyte telomere length is ablated in opposite-sex co-twins. Int J Epidemiol 43(6):1799-1805
91. Graakjaer J et al (2004) The relative lengths of individual telomeres are defined in the zygote and strictly maintained during life. Aging Cell 3(3):97-102
92. Levy D et al (2010) Genome-wide association identifies OBFC1 as a locus involved in human leukocyte telomere biology. Proc Natl Acad Sci USA 107(20):9293-9298
93. Codd V et al (2010) Common variants near TERC are associated with mean telomere length. Nat Genet 42(3):197-199
94. Mangino M et al (2012) Genome-wide meta-analysis points to CTC1 and ZNF676 as genes regulating telomere homeostasis in humans. Hum Mol Genet 21(24):5385-5394
95. Codd V et al (2013) Identification of seven loci affecting mean telomere length and their association with disease. Nat Genet 45(4):422-427
96. Takubo K et al (2002) Telomere lengths are characteristic in each human individual. Exp Gerontol 37(4):523-531
97. Hunt SC et al (2008) Leukocyte telomeres are longer in African Americans than in whites: the National Heart, Lung, and Blood Institute Family Heart Study and the Bogalusa Heart Study. Aging Cell 7(4):451-458
98. Kim S et al (2012) Association between genetic variants in DNA and histone methylation and telomere length. Plos ONE 7(7):e40504
99. Atzmon G et al (2010) Genetic variation in human telomerase is associated with telomere length in Ashkenazi centenarians. Proc Natl Acad Sci USA 107:1710-1717
100. Vasa-Nicotera M et al (2005) Mapping of a major locus that determines telomere length in humans. Am J Hum Genet 76(1):147-151
101. Weng N-P (2008) Telomere and adaptive immunity. Mech Ageing Dev 129(1-2):60-66
102. Weng NP et al (1997) Tales of tails: regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation, and aging. Immunol Rev 160:43-54
103. Son NH et al (2000) Lineage-specific telomere shortening and unaltered capacity for telomerase expression in human T and B lymphocytes with age. J Immunol 165(3):1191-1196
104. Lin J et al (2010) Analyses and comparisons of telomerase activity and telomere length in human T and B cells: insights for epidemiology of telomere maintenance. J Immunol Methods 352(1-2):71-80
105. Wolf D et al (2006) Telomere length of in vivo expanded CD4(+)CD25 (+) regulatory T-cells is preserved in cancer patients. Cancer Immunol Immunother 55(10):1198-1208
106. Broccoli D, Young JW, Delange T (1995) Telomerase activity in normal and malignant hematopoietic-Cells. Proc Natl Acad Sci USA 92(20):9082-9086
107. Xu D et al (1996) Supression of telomerase activity in HL60 cells after treatment with differentiating agents. Leukemia 10(8):1354-1357
108. Bestilny LJ et al (1996) Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines. Cancer Res 56(16):3796-3802
109. Savoysky E et al (1996) Down-regulation of telomerase activity is an early event in the differentiation of HL60 cells. Biochem Biophys Res Commun 226(2):329-334
110. Holt SE, Wright WE, Shay JW (1996) Regulation of telomerase activity in immortal cell lines. Mol Cell Biol 16(6):2932-2939
111. Sharma HW et al (1996) Telomeres, telomerase and cancer: Is the magic bullet real? Anticancer Res 16(1):511-515
112. Weng N (2001) Interplay between telomere length and telomerase in human leukocyte differentiation and aging. J Leukoc Biol 70(6):861-867
113. Chaves-Dias C et al (2001) Induction of telomerase activity during development of human mast cells from peripheral blood CD34+ cells: comparisons with tumor mast-cell lines. J Immunol 166(11):6647-6656
114. Blasco MA et al (1996) Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nat Genet 12(2):200-204
115. Nakamura TM et al (1997) Telomerase catalytic subunit homologs from fission yeast and human. Science 277(5328):955-959
116. Buchkovich KJ, Greider CW (1996) Telomerase regulation during entry into the cell cycle in normal human T cells. Mol Biol Cell 7(9):1443-1454
117. Liu KB et al (1999) Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes. Proc Natl Acad Sci USA 96(9):5147-5152
118. Antonio Moro-Garcia M, Alonso-Arias R, Lopez-Larrea C (2012) Molecular Mechanisms Involved in the Aging of the T-cell Immune Response. Curr Genom 13(8):589-602
119. Macallan DC et al (2004) Rapid turnover of effector-memory CD4(+) T cells in healthy humans. J Exp Med 200(2):255-260
120. Plunkett FJ et al (2005) The impact of telomere erosion on memory CD8+ T cells in patients with X-linked lymphoproliferative syndrome. Mech Ageing Dev 126(8):855-865
121. Fletcher JM et al (2005) Cytomegalovirus-specific CD4(+) T cells in healthy carriers are continuously driven to replicative exhaustion. J Immunol 175(12):8218-8225
122. Fritsch RD et al (2005) Stepwise differentiation of CD4 memory T cells defined by expression of CCR7 and CD27. J Immunol 175(10):6489-6497
123. Akbar AN, Vukmanovic-Stejic M (2007) Telomerase in T lymphocytes: use it and lose it? J Immunol 178(11):6689-6694
124. Deville L, Hillion J, Segal-Bendirdjian E (2009) Telomerase regulation in hematological cancers: a matter of stemness? Biochim Et Biophys Acta Mol Basis Dis 1792(4):229-239
125. Liu K, Hodes RJ, Weng N (2001) Cutting edge: telomerase activation in human T lymphocytes does not require increase in telomerase reverse transcriptase (hTERT) protein but is associated with hTERT phosphorylation and nuclear translocation. J Immunol 166(8):4826-4830
126. Kang SS et al (1999) Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. J Biol Chem 274(19):13085-13090
127. Smith LL, Coller HA, Roberts JM (2003) Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat Cell Biol 5(5):474-479
128. Li S et al (2005) Cellular and gene expression responses involved in the rapid growth inhibition of human cancer cells by RNA interference-mediated depletion of telomerase RNA. J Biol Chem 280(25):23709-23717
129. Bagheri S et al (2006) Genes and pathways downstream of telomerase in melanoma metastasis. Proc Natl Acad Sci USA 103(30):11306-11311
130. Park JI et al (2009) Telomerase modulates Wnt signalling by association with target gene chromatin. Nature 460(7251):66-72
131. Maida Y et al (2009) An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA. Nature 461(7261):230-235
132. Hoffmeyer K et al (2012) Wnt/β-catenin signaling regulates telomerase in stem cells and cancer cells. Science 336(6088):1549-1554
133. Santos JH et al (2004) Mitochondrial hTERT exacerbates free-radical-mediated mtDNA damage. Aging Cell 3(6):399-411
134. Santos JH, Meyer JN, Van Houten B (2006) Mitochondrial localization of telomerase as a determinant for hydrogen peroxide-induced mitochondrial DNA damage and apoptosis. Hum Mol Genet 15(11):1757-1768
135. Haendeler J et al (2003) Hydrogen peroxide triggers nuclear export of telomerase reverse transcriptase via Src kinase family-dependent phosphorylation of tyrosine 707. Mol Cell Biol 23(13):4598-4610
136. Ahmed S et al (2008) Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress. J Cell Sci 121(Pt 7):1046-1053
137. Haendeler J et al (2009) Mitochondrial telomerase reverse transcriptase binds to and protects mitochondrial DNA and function from damage. Arterioscler Thromb Vasc Biol 29(6):929-935
138. Saretzki G (2009) Telomerase, mitochondria and oxidative stress. Exp Gerontol 44(8):485-492
139. Indran IR, Hande MP, Pervaiz S (2011) hTERT overexpression alleviates intracellular ROS production, improves mitochondrial function, and inhibits ROS-mediated apoptosis in cancer cells. Cancer Res 71(1):266-276
140. Sharma NK et al (2012) Human telomerase acts as a hTR-independent reverse transcriptase in mitochondria. Nucleic Acids Res 40(2):712-725
141. Singhapol C et al (2013) Mitochondrial telomerase protects cancer cells from nuclear DNA damage and apoptosis. Plos ONE 8(1):e52989
142. Sahin E et al (2011) Telomere dysfunction induces metabolic and mitochondrial compromise. Nature 470(7334):359-365
143. Kim JH et al (2013) The relationship between leukocyte mitochondrial DNA copy number and telomere length in Community-Dwelling elderly women. Plos ONE 8(6):e67227
144. Lopatina NG et al (2003) Control mechanisms in the regulation of telomerase reverse transcriptase expression in differentiating human teratocarcinoma cells. Biochem Biophys Res Commun 306(3):650-659
145. Shin KH et al (2003) Hypermethylation of the hTERT promoter inhibits the expression of telomerase activity in normal oral fibroblasts and senescent normal oral keratinocytes. Br J Cancer 89(8):1473-1478
146. Zinn RL et al (2007) hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site. Cancer Res 67(1):194-201
147. Dessain SK et al (2000) Methylation of the human telomerase gene CpG island. Cancer Res 60(3):537-541
148. Devereux TR et al (1999) DNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) gene. Cancer Res 59(24):6087-6090
149. Kumari A et al (2009) Positive regulation of human telomerase reverse transcriptase gene expression and telomerase activity by DNA methylation in pancreatic cancer. Ann Surg Oncol 16(4):1051-1059
150. Kumari A, Srinivasan R, Wig JD (2009) Effect of c-MYC and E2F1 gene silencing and of 5-azacytidine treatment on telomerase activity in pancreatic cancer-derived cell lines. Pancreatology 9(4):360-368
151. Guilleret I et al (2002) Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity. Int J Cancer 101(4):335-341
152. Takakura M et al (2001) Telomerase activation by histone deacetylase inhibitor in normal cells. Nucleic Acids Res 29(14):3006-3011
153. Hou M et al (2002) The histone deacetylase inhibitor trichostatin a derepresses the telomerase reverse transcriptase (hTERT) gene in human cells. Exp Cell Res 274(1):25-34
154. Murakami J et al (2005) Effects of histone deacetylase inhibitor FR901228 on the expression level of telomerase reverse transcriptase in oral cancer. Cancer Chemother Pharmacol 56(1):22-28
155. Zhu K et al (2008) Telomerase expression and cell proliferation in ovarian cancer cells induced by histone deacetylase inhibitors. Arch Gynecol Obstet 277(1):15-19
156. Khaw AK et al (2007) Inhibition of telomerase activity and human telomerase reverse transcriptase gene expression by histone deacetylase inhibitor in human brain cancer cells. Mutat Res 625(1-2):134-144
157. Atkinson SP et al (2005) Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters. Cancer Res 65(17):7585-7590
158. Sui X et al (2013) Epigenetic regulation of the human telomerase reverse transciptase gene: a potential therapeutic target for the treatment of leukemia (review). Oncol Lett 6(2):317-322
159. Garcia-Cao M et al (2004) Epigenetic regulation of telomere length in mammalian cells by the Suv39h1 and Suv39h2 histone methyltransferases. Nat Genet 36(1):94-99
160. Gonzalo S et al (2006) DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat Cell Biol 8(4):416-424
161. Scheuring UJ, Sabzevari H, Theofilopoulos AN (2002) Proliferative arrest and cell cycle regulation in CD8(+)CD28(-) versus CD8(+)CD28(+) T cells. Hum Immunol 63(11):1000-1009
162. Bellon M et al (2010) HTLV-I Tax-dependent and -independent events associated with immortalization of human primary T lymphocytes. Blood 115(12):2441-2448
163. Lu QJ et al (2003) DNA methylation and chromatin structure regulate T cell perforin gene expression. J Immunol 170(10):5124-5132
164. Liu Y et al (2009) DNA methylation inhibition increases T cell KIR expression through effects on both promoter methylation and transcription factors. Clin Immunol 130(2):213-224
165. Chen YX et al (2010) Decreased ERK and JNK signaling contribute to gene overexpression in "senescent" CD4+ CD28-T cells through epigenetic mechanisms. J Leukoc Biol 87(1):137-145
166. Gonzalo S et al (2005) Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin. Nat Cell Biol 7(4):420-428
167. Garcia-Cao M et al (2002) A role for the Rb family of proteins in controlling telomere length. Nat Genet 32(3):415-419
168. Makarov VL et al (1993) Nucleosomal organization of telomere-specific chromatin in rat. Cell 73(4):775-787
169. Tommerup H, Dousmanis A, Delange T (1994) Unusual chromatin in human telomeres. Mol Cell Biol 14(9):5777-5785
170. Baur JA et al (2001) Telomere position effect in human cells. Science 292(5524):2075-2077
171. Koering CE et al (2002) Human telomeric position effect is determined by chromosomal context and telomeric chromatin integrity. EMBO Rep 3(11):1055-1061
172. Samper E, Flores JA, Blasco MA (2001) Restoration of telomerase activity rescues chromosomal instability and premature aging in Terc(-/-) mice with short telomeres. EMBO Rep 2(9):800-807
173. Hemann MT et al (2001) The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 107(1):67-77
174. Azzalin CM et al (2007) Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends. Science 318(5851):798-801
175. Schoeftner S, Blasco MA (2008) Developmentally regulated transcription of mammalian telomeres by DNA-dependent RNA polymerase II. Nat Cell Biol 10(2):228-236
176. Nergadze SG et al (2009) CpG-island promoters drive transcription of human telomeres. RNA 15(12):2186-2194
177. Redon S, Reichenbach P, Lingner J (2010) The non-coding RNA TERRA is a natural ligand and direct inhibitor of human telomerase. Nucleic Acids Res 38(17):5797-5806
178. Meyerson M et al (1997) hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90(4):785-795
179. Bodnar AG et al (1998) Extension of life-span by introduction of telomerase into normal human cells. Science 279(5349):349-352
180. Horikawa I et al (1999) Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res 59(4):826-830
181. Ulaner GA et al (1998) Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res 58(18):4168-4172
182. Ulaner GA et al (2000) Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium. Int J Cancer 85(3):330-335
183. Holt SE et al (1999) Functional requirement of p23 and Hsp90 in telomerase complexes. Genes Dev 13(7):817-826
184. Cong YS, Wright WE, Shay JW (2002) Human telomerase and its regulation. Microbiol Mol Biol Rev 66(3):407-425